TL;DR
This paper presents the complete genome sequence of Citrobacter freundii strain SL151, a highly multidrug-resistant (MDR) human urine isolate from Sierra Leone. This detailed genomic information is crucial for understanding the genetic basis of its extensive antibiotic resistance, which is a growing public health concern, particularly in hospital settings.
What Problem Does This Paper Address?
Citrobacter freundii is a Gram-negative bacterium that's becoming a significant cause of hospital-acquired urinary tract infections (UTIs). What's particularly concerning is its increasing resistance to multiple classes of antibiotics, making infections difficult to treat. This resistance isn't just a clinical problem; these bacteria also act as reservoirs for antibiotic resistance determinants (ARDs), potentially spreading these genes to other pathogens. A recent study in Sierra Leone found a surprisingly high number of C. freundii isolates from UTI patients exhibiting MDR phenotypes. To understand the genetic underpinnings of this widespread resistance, the researchers sequenced the genome of one such highly resistant isolate, strain SL151.
Methods
The researchers employed Pacific Biosciences (PacBio) RS II single-molecule real-time (SMRT) sequencing technology to obtain a high-quality, finished genome sequence. Genomic DNA was extracted and prepared into a 20-kb insert library. After sequencing, the raw reads were assembled and polished using SMRT Analysis and HGAP.2. Gene prediction and annotation were performed using GeneMarkS+ and the NCBI Prokaryotic Genome Annotation Pipeline. To identify the genetic basis of antibiotic resistance, a standard BLAST query against the Comprehensive Antibiotic Resistance Database (CARD) was conducted.
Datasets
The primary dataset is the newly sequenced genome of Citrobacter freundii strain SL151. This genome sequence has been deposited in public databases (DDBJ/EMBL/GenBank) under accession numbers CP016952, CP017058, and CP017059. The researchers also utilized the Comprehensive Antibiotic Resistance Database (CARD) for comparative analysis of resistance genes.
Key Insights and Ideas
- Mosaic Plasmid-Mediated ARD Accumulation: The genome reveals that C. freundii accumulates antibiotic resistance determinants (ARDs) in a mosaic fashion, primarily through plasmids. This suggests a dynamic and efficient mechanism for acquiring and spreading resistance.
- Complex Integrons and Transposons: The presence of a composite class 1 integron on one plasmid, rich in ARDs, and an IS26-flanked composite transposon on another, highlights the sophisticated genetic elements that contribute to multidrug resistance.
- Genotypic Basis for Phenotypic Resistance: The genomic analysis directly links observed MDR phenotypes to specific ARDs, providing a clear genotype-phenotype correlation. This is crucial for understanding how resistance emerges and evolves.
- Potential for Gene Transfer: The identification of ARDs in mobile genetic elements like plasmids and integrons strongly suggests their potential for transfer to other bacteria, contributing to the broader spread of antibiotic resistance.
Key Results
The finished genome of C. freundii strain SL151 comprises a circular chromosome of 5,073,255 bp and two circular plasmids (210,673 bp and 154,967 bp), totaling 5,438,895 bp. The genome contains 5,537 predicted coding sequences. A BLAST query against the CARD identified 97 resistance-associated genes. Notably, 36 of these genes showed ≥95% nucleotide identity to CARD reference sequences. The chromosome harbors the intrinsic AmpC cephalosporinase and a truncated qnrB gene. The larger plasmid carries genes conferring resistance to aminoglycosides, fluoroquinolones, and sulfonamides, including blaTEM-1 and blaCTX-M-15. The smaller plasmid contains a complex integron with multiple resistance genes.
Limitations and Future Work
The paper focuses on a single isolate, SL151, which represents a highly resistant strain from a specific geographical location. While this provides valuable insight, it may not fully capture the diversity of resistance mechanisms across all C. freundii strains or in different environments. Future work could involve sequencing a broader range of isolates from various sources and geographical regions to gain a more comprehensive understanding of ARD dissemination and evolution in C. freundii. Further functional studies to confirm the role of specific ARDs and mobile genetic elements in conferring resistance phenotypes would also be beneficial.
Summary updated